Zanubrutinib in Bing Neel syndrome: efficacy and tolerability: LYMPHOMA

Anne-Marie L Becking; Johannes P M van de Mortel; Oliver Tomkins; Thijs W H Flinsenberg; Nicole Japzon; Marie José Kersten; Jahanzaib Khwaja; Saskia Kuipers; Henriette Levenga; Sean McKeague; Stephen Opat; Ross T Salvaris; Sherif Seif; Sheeba K Thomas; Alexander F J E Vrancken; Shirley D'Sa; Monique C Minnema; Josephine M I Vos

doi:10.1038/s41375-025-02581-y

Zanubrutinib in Bing Neel syndrome: efficacy and tolerability: LYMPHOMA

Anne-Marie L Becking^*, Johannes P M van de Mortel, Oliver Tomkins, Thijs W H Flinsenberg, Nicole Japzon, Marie José Kersten, Jahanzaib Khwaja, Saskia Kuipers, Henriette Levenga, Sean McKeague, Stephen Opat, Ross T Salvaris, Sherif Seif, Sheeba K Thomas, Alexander F J E Vrancken, Shirley D'Sa, Monique C Minnema, Josephine M I Vos

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	1260–1264
Journal	Leukemia
Volume	39
Early online date	31 Mar 2025
DOIs	https://doi.org/10.1038/s41375-025-02581-y
Publication status	Published - 2025

Access to Document

10.1038/s41375-025-02581-yLicence: CC BY-NC-ND

s41375-025-02581-yFinal published version, 739 KBLicence: CC BY-NC-ND

Cite this

Becking, A.-M. L., van de Mortel, J. P. M., Tomkins, O., Flinsenberg, T. W. H., Japzon, N., Kersten, M. J., Khwaja, J., Kuipers, S., Levenga, H., McKeague, S., Opat, S., Salvaris, R. T., Seif, S., Thomas, S. K., Vrancken, A. F. J. E., D'Sa, S., Minnema, M. C., & Vos, J. M. I. (2025). Zanubrutinib in Bing Neel syndrome: efficacy and tolerability: LYMPHOMA. Leukemia, 39, 1260–1264. https://doi.org/10.1038/s41375-025-02581-y

@article{12e903f0bb844aeabd69c81a342575c8,

title = "Zanubrutinib in Bing Neel syndrome: efficacy and tolerability: LYMPHOMA",

author = "Becking, {Anne-Marie L} and {van de Mortel}, {Johannes P M} and Oliver Tomkins and Flinsenberg, {Thijs W H} and Nicole Japzon and Kersten, {Marie Jos{\'e}} and Jahanzaib Khwaja and Saskia Kuipers and Henriette Levenga and Sean McKeague and Stephen Opat and Salvaris, {Ross T} and Sherif Seif and Thomas, {Sheeba K} and Vrancken, {Alexander F J E} and Shirley D'Sa and Minnema, {Monique C} and Vos, {Josephine M I}",

year = "2025",

doi = "10.1038/s41375-025-02581-y",

language = "English",

volume = "39",

pages = "1260–1264",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

}

Becking, A-ML, van de Mortel, JPM, Tomkins, O, Flinsenberg, TWH, Japzon, N, Kersten, MJ, Khwaja, J, Kuipers, S, Levenga, H, McKeague, S, Opat, S, Salvaris, RT, Seif, S, Thomas, SK, Vrancken, AFJE, D'Sa, S, Minnema, MC & Vos, JMI 2025, 'Zanubrutinib in Bing Neel syndrome: efficacy and tolerability: LYMPHOMA', Leukemia, vol. 39, pp. 1260–1264. https://doi.org/10.1038/s41375-025-02581-y

TY - JOUR

T1 - Zanubrutinib in Bing Neel syndrome

T2 - efficacy and tolerability: LYMPHOMA

AU - Becking, Anne-Marie L

AU - van de Mortel, Johannes P M

AU - Tomkins, Oliver

AU - Flinsenberg, Thijs W H

AU - Japzon, Nicole

AU - Kersten, Marie José

AU - Khwaja, Jahanzaib

AU - Kuipers, Saskia

AU - Levenga, Henriette

AU - McKeague, Sean

AU - Opat, Stephen

AU - Salvaris, Ross T

AU - Seif, Sherif

AU - Thomas, Sheeba K

AU - Vrancken, Alexander F J E

AU - D'Sa, Shirley

AU - Minnema, Monique C

AU - Vos, Josephine M I

PY - 2025

Y1 - 2025

UR - http://www.scopus.com/inward/record.url?scp=105001832758&partnerID=8YFLogxK

U2 - 10.1038/s41375-025-02581-y

DO - 10.1038/s41375-025-02581-y

M3 - Letter

C2 - 40164717

SN - 0887-6924

VL - 39

SP - 1260

EP - 1264

JO - Leukemia

JF - Leukemia

ER -

Zanubrutinib in Bing Neel syndrome: efficacy and tolerability: LYMPHOMA

Access to Document

Other files and links

Cite this